Prepared by MerrillDirect

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

___________

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 15, 2001

 

INTEGRA LIFESCIENCES HOLDINGS CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

0-26224

51-0317849

(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

 

311-C Enterprise Drive  
Plainsboro, New Jersey

08536

(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number,  
including area code:  (609) 275-0500

 

 

Not Applicable

(Former name or former address, if changed since last report)

Item 5. Other Events

The Company's Annual Meeting of Stockholders was held on May 15, 2001 and in connection therewith, proxies were solicited by management pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. An aggregate of 17,642,155 shares of the Company's common stock ("Common Stock"), 100,000 shares of Series B Preferred Stock (which are convertible into 2,617,801 shares of Common Stock), and 54,000 shares of Series C Preferred Stock (which are convertible into 600,000 shares of Common Stock) (collectively, "Shares") were outstanding and entitled to a vote at the meeting. At the meeting the following matters (not including ordinary procedural matters) were submitted to a vote of the holders of Shares, with the results indicated below:

1. Election of directors to serve until the 2002 Annual Meeting. The following persons, all of whom were serving as directors and were management's nominees for election, were elected. There was no solicitation in opposition to such nominees. The tabulation of votes was as follows:

Nominee
For
Withheld
Keith Bradley 18,100,636 405,740
Richard E. Caruso 18,100,636 405,740
Stuart M. Essig 16,544,957 1,961,419
Neil Moszkowski 18,101,136 405,240
George W. McKinney, III 16,537,857 1,968,519
James M. Sullivan 18,101,136 405,240

2. Approval of the Company's 2001 Equity Incentive Plan. The Company's 2001 Equity Incentive Plan was approved. The tabulation of votes was as follows:

For
Against
Abstentions
13,811,174 2,392,352 22,910

3. Ratification and approval of an amendment to the Company’s Certificate of Designation, Rights and Preferences of Series B Convertible Preferred Stock, the purpose of which was to ensure that the rights and preferences of the Series B Convertible Preferred Stock would be substantially identical to the rights and preferences of the Series C Convertible Preferred Stock. This amendment was approved. The tabulation of votes was as follows:

For
Against
Abstentions
16,116,674 74,884 34,878

4. Approval of an amendment to the Company’s Certificate of Designation, Rights and Preferences of Series B Convertible Preferred Stock, the purpose of which is to make certain changes to clarify the numbering of certain paragraphs and internal references contained therein. This amendment was approved. The tabulation of votes was as follows:

For
Against
Abstentions
16,135,626 57,625 33,185

5. Approval of an amendment to the Company’s Certificate of Designation, Rights and Preferences of Series C Convertible Preferred Stock, the purpose of which is to make certain changes to clarify the numbering of certain paragraphs and internal references contained therein. This amendment was approved. The tabulation of votes was as follows:

For
Against
Abstentions
16,135,020 58,204 33,212

6. Ratification of independent auditors. The appointment of PricewaterhouseCoopers LLP as the Company's independent auditors for the current fiscal year was ratified. The tabulation of votes was as follows:

For
Against
Abstentions
18,477,510 22,744 6,122

 

ITEM 7.            Financial Statements and Exhibits.

             (c)         Exhibits.

Exhibit Number
(Referenced to
 Item 601 of
 Regulation S-K)

Description of Exhibit
(3)(i).1 Second Amendment to Certificate of Rights, Designations
   and Preferences of Series B Convertible Preferred Stock
   
(3)(i).2 First Amendment to Certificate of Rights, Designations and
   Preferences of Series C Convertible Preferred Stock

 

 

SIGNATURES

 

                           Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  INTEGRA LIFESCIENCES HOLDINGS
CORPORATION
   
Date:  May 25, 2001 By:      /s/ Stuart M. Essig
      Stuart M. Essig, President and
     Chief Executive Officer
 

INDEX OF EXHIBITS

Exhibit No.
Description of Exhibit
(3)(i).1 Second Amendment to Certificate of Rights, Designations
   and Preferences of Series B Convertible Preferred Stock
   
(3)(i).2 First Amendment to Certificate of Rights, Designations and
   Preferences of Series C Convertible Preferred Stock